We are live on ! Find out more
ARCK

Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock

Delisted

ARCK was delisted on the 12th of January, 2023.

24 hedge funds and large institutions have $59.1M invested in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

34.42% more ownership

Funds ownership: 0% → 34.42% (+34%)

Holders
24
Holders Change
+24
Holders Change %
–
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
–
Reduced
–
Closed
–
Calls
$33K
Puts
–
Net Calls
+$33K
Net Calls Change
+$33K

ARCK Hedge Fund Activity: Q4 2021 in Review

24 of the 6,519 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) for Q4 2021, worth a combined $59.1M.

Buyers outnumbered sellers: 24 funds opened new ARCK positions and 0 closed out — a net gain of 24 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Beryl Capital Management, opening a new position worth an estimated $14.9M.

  • 24 institutional investors held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $59.1M of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock stock for Q4 2021.
  • 24 funds opened new Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock positions in Q4 2021 and 0 closed out, a net change of +24 holders.
  • The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock buyer in Q4 2021 was Beryl Capital Management, an estimated $14.9M added.

Based on aggregated 13F filings for Q4 2021.